|
Volumn 100, Issue 6, 2002, Pages 2077-2080
|
The caspase inhibitor z-VAD is more effective than CD18 adhesion blockade in reducing muscle ischemia-reperfusion injury: Implication for clinical trials
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BENZYLOXYCARBONYLVALYLALANYLASPARTYL FLUOROMETHYL KETONE;
CASPASE;
CASPASE INHIBITOR;
CD18 ANTIGEN;
CREATINE KINASE;
MONOCLONAL ANTIBODY;
ANIMAL EXPERIMENT;
AORTA CLAMPING;
APOPTOSIS;
ARTICLE;
CONTROLLED STUDY;
DRUG EFFICACY;
ENZYME INHIBITION;
ENZYME RELEASE;
LEUKOCYTE ADHERENCE;
MOUSE;
MUSCLE INJURY;
MUSCLE ISCHEMIA;
NONHUMAN;
PRIORITY JOURNAL;
REPERFUSION INJURY;
|
EID: 0037105527
PISSN: 00064971
EISSN: None
Source Type: Journal
DOI: 10.1182/blood-2002-03-0752 Document Type: Article |
Times cited : (36)
|
References (15)
|